NTN1 and cardiovascular disorder: Netrin-1 is also emerging as a therapeutic target in cardiovascular disease [4], having been shown in pre-clinical studies to modulate atherogenesis via the control of arterial inflammation [5], as well as exerting cardio- and renoprotective actions [6, 7]; and in this context, enhancing netrin-1 signalling may be desirable.